Invitation to manufacturers of Zinc-Sulfate to submit an Expression of Interest (EOI) for product evaluation to the WHO Prequalification of Medicines Programme (November[removed]To support national and global efforts to in

First Page		Document Content
Date: 2011-02-07 04:46:32 Pharmaceutical industry Pharmaceuticals policy Pharmacy Food safety Good manufacturing practice National Institute for Health and Clinical Excellence Zinc Pharmaceutical sciences Chemistry Pharmacology		Invitation to manufacturers of Zinc-Sulfate to submit an Expression of Interest (EOI) for product evaluation to the WHO Prequalification of Medicines Programme (November[removed]To support national and global efforts to in Add to Reading List Source URL: apps.who.int Download Document from Source Website File Size: 40,36 KB Share Document on Facebook

	RETAIL PHARMACY CASE STUDY Retail Pharmacy and Healthcare Distributor Case Study Global powerhouse gains visibility, strategic power and clarity with KeyedIn Projects SaaS solution DocID: 1xVz3 - View Document
	Case Study: WESTERN MARYLAND PHARMACY Improving Clinical Outcomes and Decreasing Acetaminophen Costs by 78% with Diver Platform DocID: 1xTm3 - View Document
	PDF Document DocID: 1xQi5 - View Document
	PDF Document DocID: 1xNTr - View Document
	PDF Document DocID: 1xIyF - View Document